Medical Weght Loss

Medical Weight Loss

In the Serene Infusion and Wellness Lounge weight loss management program, we understand that weight loss is an integral part of healing. We also recognize that the process of losing can be quite challenging because of each person’s medical comorbidity.

We offer oral medications and injectable peptides as an adjunct therapy to a healthy diet and increased or modified physical activity for weight management in adults with an elevated BMI.  We use compounded Tirzepatide and Semaglutide patient-specific medication created in a state Board of Pharmacy or FDA-licensed compounding facility per a prescription from a licensed healthcare professional. Compounded drugs are required to exclusively use ingredients from FDA-licensed facilities, and test sterile compounds for potency, sterility, and purity. While compounded drugs are legal, they do not undergo pre-market approval from the FDA as they are not made in large batches for the public. Compounds are made based on specific orders from a medical professional. Therefore the dose, route of administration, and efficacy may differ from commercially available, brand-name drugs.

Serene Infusion and Wellness Lounge exclusively works with licensed, sterile compounding pharmacies in the United States.

According to the FDA, Obesity and overweight are serious conditions that can be associated with some of the leading causes of death such as heart disease, stroke and diabetes.”  (John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDA’s Center for Drug Evaluation and Research)

Prices listed on our booking page.


This is a glucagon-like peptide-1 receptor agonist (GLP-1), One role of GLP-1 is to prompt the body to produce more insulin, which reduces blood sugar (glucose). But GLP-1 in higher amounts also interacts with the parts of the brain that suppress your appetite and signal you to feel full. When used in conjunction with diet and exercise, it can cause significant weight loss — and a reduced risk of cancer, diabetes and heart disease — in people who are obese or overweight.

An early study of 2,000 obese adults compared people using Semaglutide plus a diet and exercise program with people who made the same lifestyle changes without Semaglutide. After 68 weeks, half of the participants using Semaglutide lost 15% of their body weight, and nearly a third lost 20%. Participants who incorporated only lifestyle changes lost about 2.4% of their weight.

The FDA recommends Semaglutide for weight loss if you meet one of the following criteria:

  • Have a body mass index (BMI) of 27kg/m2 or greater and at least one weight-related condition, such as high blood pressure, Type 2 diabetes or high cholesterol.
  • Have a BMI of 30kg/m2 or greater

What are the side effects of semaglutide injections?
The side effects of semaglutide are typically mild — especially when compared to the complications associated with overweight and obesity.

  • Dizziness
  • Fatigue
  • Gastrointestinal issues, such as diarrhea, constipation, and gassiness
  • Headache


Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist, representing a new class of medicines studied for the treatment of obesity. is a single peptide that triggers the body’s receptors for GIP and GLP-1, two natural incretin hormones. Tirzepatide can also be administered with certain vitamin therapies that enhance the process.

GIP has decreased food intake and increased energy expenditure, resulting in weight reductions. Combined with a GLP-1 receptor agonist, it has a more significant effect on glucose and body weight effects.


  • Substantial A1C reductions
  • Boosted weight loss
  • Improvements in cardiometabolic measures
  • Reduced appetite
How to Use Semagludtide or Tirzepatide
  • Medication is injected under the skin (subcutaneously) of your stomach (abdomen), thigh, or upper arm.
  • Use Medication 1 time each week, at any time of the day.
  • Do not mix Tirzepatide, and or Semaglutide together or with any other medication.
  • Change (rotate) your injection site with each weekly injection. Do not use the same site for each injection.
  • If you take too much medication, call your healthcare provider or seek medical advice promptly.
Avoid Semaglutide/ Tirzepatide if you have:
  • History of medullary thyroid cancer
  • History of gallbladder disease
  • History of pancreatitis
  • Multiple endocrine neoplasia syndrome type 2 (MEN2)
  • Bowel Obstruction


This is an approved oral weight loss medication for people who are afraid of injection or have some contraindications for the GLP-1 and GIP medications.

CONTRAVE combines 2 medications that together reduce hunger and control cravings to help you lose weight and keep it off: bupropion HCl and naltrexone HCl. Both medicines have well-established safety profiles and have been prescribed by doctors for other conditions for more than 30 years.It contains naltrexone HCI, which is more commonly used to treat substance abuse conditions, and bupropion HCI (brand name – Wellbutrin), which is a very popular antidepressant. These two medications work together in the brain to help down-regulate hunger signals. The COR-I, COR-II, COR-BMOD, and COR-Diabetes trials demonstrated 8.1-11.5% weight loss over 2 years.

History of Bipolar Disorder; Schizophrenia; Hypertension; Concurrent substance use disorder.

Activation of mania in bipolar patients (<1%); Insomnia (11-40%)